The Enterprise Value as of November 2024 (TTM) for iSpecimen Inc. (ISPC) is 1.48M

According to iSpecimen Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.48M. This represents a change of -98.08% compared to the average of 77.12M of the last 4 quarters.

iSpecimen Inc. (ISPC) Historical Enterprise Value (quarterly & annually)

How has ISPC Enterprise Value performed in the past?

The mean historical Enterprise Value of iSpecimen Inc. over the last ten years is 694.87M. The current 1.48M Enterprise Value has changed -78.71% with respect to the historical average. Over the past ten years (40 quarters), ISPC's Enterprise Value was at its highest in in the December 2021 quarter at 1.06B. The Enterprise Value was at its lowest in in the September 2019 quarter at 0.

iSpecimen Inc. (ISPC) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of iSpecimen Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

iSpecimen Inc. (ISPC) Average Enterprise Value

How has ISPC Enterprise Value performed in the past?

The current Enterprise Value of iSpecimen Inc. (ISPC) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

iSpecimen Inc. (ISPC) Enterprise Value vs. Peers

How is ISPC’s Enterprise Value compared to its peers?

iSpecimen Inc.’s Enterprise Value is greater than Genetron Holdings Limited (-48977790.00), less than Olink Holding AB (publ) (3.16B), less than FONAR Corporation (81.90M), less than Castle Biosciences, Inc. (859.09M), less than Exagen Inc. (44.08M), less than OncoCyte Corporation (44.92M), less than Personalis, Inc. (269.07M), less than Interpace Biosciences, Inc. (17.16M), less than Trinity Biotech plc (108.44M), less than HTG Molecular Diagnostics, Inc. (2.05M), greater than Intelligent Bio Solutions Inc. (474.54K), less than bioAffinity Technologies, Inc. (19.06M), less than SeqLL Inc. (264.18M), less than T2 Biosystems, Inc. (29.85M), less than Biocept, Inc. (4.96M),

Build a custom stock screener for iSpecimen Inc. (ISPC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like iSpecimen Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

iSpecimen Inc. (ISPC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like iSpecimen Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.